Dexterra Group (DXT) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
8 May, 2026Executive summary
Achieved record 2025 results with revenue over $1.04 billion, Adjusted EBITDA of $122.8 million, and net earnings of $40.8 million, driven by strong operational execution and strategic acquisitions including PVC and Right Choice.
Completed onboarding and integration of Right Choice and PVC, expanding U.S. facilities management and Canadian workforce accommodations.
Delivered robust shareholder returns through share price appreciation of over 60% in 14 months, buybacks, and a 14% dividend increase to $0.40 per share.
Strategic investments included a 40% stake in PVC and the acquisition of Right Choice, totaling $153 million.
1,483,900 shares were repurchased and cancelled under the NCIB at a total cost of $11.7 million.
Financial highlights
Q4 2025 revenue was $271 million, up 9% year-over-year; Adjusted EBITDA rose to $33 million, with margins expanding to 12% from 10.7% in Q4 2024.
Full-year 2025 revenue reached $1.041 billion, Adjusted EBITDA was $122.8 million, and Free Cash Flow was $60 million.
Net earnings per share for Q4 2025 were $0.12, up from $0.11 in Q4 2024; annual EPS rose to $0.65 from $0.31.
Return on equity was 15% in 2025.
Net debt at year-end was 1.6x Adjusted EBITDA (about $200 million), up from $67.9 million in 2024 due to acquisitions.
Outlook and guidance
Strong pipeline for 2026 in support services and asset-based services, with Adjusted EBITDA margins expected to exceed 9% in support services and remain 30%-40% in asset-based services.
Focus on leveraging PVC partnership for U.S. growth and integrating Right Choice.
Anticipates Adjusted EBITDA conversion to Free Cash Flow above 50% in 2026.
Expects continued strong activity in nation-building, defense, and infrastructure projects, with upside potential.
Net debt expected to decrease in 2026, absent further acquisitions.
Latest events from Dexterra Group
- Q1 2026 revenue up 15% and adjusted EBITDA up 32%, with strong margins and positive outlook.DXT
Q1 20267 May 2026 - Board and auditor reappointed; strong growth and support services expansion prioritized.DXT
AGM 20242 Apr 2026 - Record financials, all proposals approved, with focus on growth, M&A, and sustainability.DXT
AGM 20252 Apr 2026 - Strong 2025 performance, strategic acquisitions, and sustainability drive growth and returns.DXT
Corporate presentation1 Apr 2026 - Q2 2024 revenue grew 18.1% year-over-year, driven by WAFES and IFM gains, with higher margins.DXT
Q2 20241 Apr 2026 - Q3 revenue up 1.5% to $269.7M, strong IFM growth, Modular business sold, outlook robust.DXT
Q3 20241 Apr 2026 - Record 2024 revenue, margin gains, and strong cash flow conversion drive positive outlook.DXT
Q4 202425 Dec 2025 - Q1 2025 delivered 29% EBITDA growth, 15% ROE, and strong Support Services performance.DXT
Q1 202524 Nov 2025 - Strong Q2 results, $30M EBITDA, major acquisitions, and a 14% dividend hike boost outlook.DXT
Q2 202523 Nov 2025